Evidence map›Paper›PMID 31933478›Full record

ArticleeLife2020

Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model.

Magdalena Kasendra, Raymond Luc, Jianyi Yin, Dimitris V Manatakis, Gauri Kulkarni, Carolina Lucchesi, Josiah Sliz, Athanasia Apostolou, Laxmi Sunuwar, Jenifer Obrigewitch and 4 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 205 citations in OpenAlex.

  1. Review
  2. Building and regenerating intestines by manipulating intestinal stem cells.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. New developments and applications of human organoids.Nature reviews. Molecular cell biology · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Novel emerging cell and organoid systems for the study of drug metabolism and toxicity in humans.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Magdalena Kasendra *Emulate Inc, Boston, United States.ORCID 0000-0002-6376-2489
Raymond Luc *Emulate Inc, Boston, United States.
Jianyi YinDepartment of Medicine, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, United States.
Dimitris V ManatakisEmulate Inc, Boston, United States.
Gauri KulkarniEmulate Inc, Boston, United States.
Carolina LucchesiEmulate Inc, Boston, United States.
Josiah SlizEmulate Inc, Boston, United States.
Athanasia ApostolouEmulate Inc, Boston, United States.
Laxmi SunuwarDepartment of Medicine, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, United States.
Jenifer ObrigewitchEmulate Inc, Boston, United States.
Kyung-Jin JangEmulate Inc, Boston, United States.
Geraldine A HamiltonEmulate Inc, Boston, United States.
Mark DonowitzDepartment of Medicine, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, United States.
Katia KaralisEmulate Inc, Boston, United States.
Emulate (United States) · USJohns Hopkins University · USNational and Kapodistrian University of Athens · GR

Funding

Translational Research Enhancement CoreP30DK089502 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ZACHOS, NICHOLAS CONSTANTINE · 2011 to 2020
$12.0M
Translational Approaches to Develop Drug Therapy for DiarrheaR24DK099803 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI DONOWITZ, MARK · 2014 to 2019
$8.9M
Mechanisms and Correction of Abnormal Bicarbonate Secretion by DRA in DiarrheaR01DK116352 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI TSE, CHUNG-MING · 2019 to 2022
$2.2M
NIDDK NIH HHS P30 DK089502NIDDK NIH HHS R01 DK116352NIDDK NIH HHS R24 DK099803
6 · The paper itself

Abstract

Induction of intestinal drug metabolizing enzymes can complicate the development of new drugs, owing to the potential to cause drug-drug interactions (DDIs) leading to changes in pharmacokinetics, safety and efficacy. The development of a human-relevant model of the adult intestine that accurately predicts CYP450 induction could help address this challenge as species differences preclude extrapolation from animals. Here, we combined organoids and Organs-on-Chips technology to create a human Duodenum Intestine-Chip that emulates intestinal tissue architecture and functions, that are relevant for the study of drug transport, metabolism, and DDI. Duodenum Intestine-Chip demonstrates the polarized cell architecture, intestinal barrier function, presence of specialized cell subpopulations, and

Indexed as

Drug InteractionsAnimalsATP Binding Cassette Transporter, Subfamily BCaco-2 CellsComputational BiologyCytochrome P-450 CYP3ADrug Evaluation, PreclinicalDuodenumGene Expression ProfilingGene Expression RegulationHumansMicrovilliOrgan Culture TechniquesOrganoidsPermeabilityTranscriptomeABCB1 protein, humanATP Binding Cassette Transporter, Subfamily BCYP3A4 protein, humanCytochrome P-450 CYP3Acell biologyCYP3A4drug metabolismdrug transportduodenumhumanorganoidsOrgans-on-Chips

Identifiers

PMID31933478
PMCPMC6959988
OpenAlexW2999902773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.